Timothy Larson

Medical Director, Early Phase Therapeutics Program, Cancer Research Center and Investigator, Metro-Minnesota Community Oncology Research Consortium · University of Minnesota

Credentials: · · · · ·

History

Early Phase Therapeutics Program · University of Minnesota
Present

Oncology & Hematology: Sacramento Medical Center
1994–1995
Internal Medicine
University of California Davis Health
1989–1990
Univ of California, San Francisco Sch of Med
1985–1989

Research

A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer
Clinical Cancer Research · 2010 · 202 citations
Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study
Journal of Clinical Oncology · 2009 · 159 citations
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
EClinicalMedicine · 2023 · 100 citations

Arkadiusz Dudek
4 papers
AC
Allen Cohn
3 papers
PK
Priya Kumar
2 papers · 1 as a fellow
RC
Roger Cohen
2 papers
VC
Vivian Cline
2 papers
Aditya Bardia
1 paper
Adnan Alseidi
1 paper
Ajay Dhakal
1 paper
AA
Ajjai Alva
1 paper
Amit Mahipal
1 paper
AP
Andrew Paulson
1 paper
Anthony Olszanski
1 paper